Technology & Health

WHO warns against use of remdesivir for hospitalised Covid-19 patients

WHO warns against use of remdesivir for hospitalised Covid-19 patients

Gilead’s drug remdesivir is not recommended for patients hospitalised with Covid-19, regardless of how ill they are, as there is no evidence it improves survival or reduces the need for ventilation, a World Health Organization panel said on Friday. “The ... panel found a lack of evidence that remdesivir improved outcomes that matter to patients such as reduced mortality, need for mechanical ventilation, time to clinical improvement, and others,” the guideline said.

Click here to read more-->
×